Assessment of the Pharmacogenomics Educational Needs of Pharmacists

被引:147
作者
McCullough, Kristen B. [1 ]
Formea, Christine M. [1 ]
Berg, Kevin D. [1 ]
Burzynski, Julianna A. [1 ]
Cunningham, Julie L. [1 ]
Ou, Narith N. [1 ]
Rudis, Maria I. [1 ]
Stollings, Joanna L. [1 ]
Nicholson, Wayne T. [2 ]
机构
[1] Mayo Clin, Dept Pharm Serv, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
pharmacogenomics; needs assessment; genetic testing; continuing education; survey; THERAPY; PHYSICIANS;
D O I
10.5688/ajpe75351
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Objectives. To evaluate the self-perceived knowledge and confidence of inpatient and outpatient pharmacists in applying pharmacogenomics information to clinical practice. Methods. A 19-question multiple-choice, electronic needs-assessment survey instrument was distributed to 480 inpatient and outpatient pharmacists in a large, academic, multi-campus healthcare system. Results. The survey response rate was 64% (303). Most respondents (85%) agreed that pharmacists should be required to be knowledgeable about pharmacogenomics, and 65% agreed that pharmacists should be capable of providing information on the appropriate use of pharmacogenomics testing. Sixty-three percent felt they could not accurately apply the results of pharmacogenomics tests to drug-therapy selection, dosing, or monitoring. Conclusion. Pharmacists believe pharmacogenomics knowledge is important to the profession, but they lack the knowledge and self-confidence to act on the results of pharmacogenomics testing and may benefit from pharmacogenomics education.
引用
收藏
页数:6
相关论文
共 30 条
[1]  
*AM SOC HLTH SYST, ASHP FORM MAN POL PO
[2]   Continuing-education programs in pharmacogenomics for pharmacists [J].
Brock, TP ;
Faulkner, CM ;
Williams, DM ;
Smith, SR .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (08) :722-725
[3]   General practitioners' and pharmacists' perceptions of the role of community pharmacists in delivering clinical services [J].
Bryant, Linda J. M. ;
Coster, Gregor ;
Gamble, Greg D. ;
McCormick, Ross N. .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2009, 5 (04) :347-362
[4]  
Carter BL, 2007, PHARMACOTHERAPY, V27, P312
[5]  
Cavallari LH, 2010, PHARMACOTHERAPY, V30, pe228
[6]   Using CAPE outcome-based goals and objectives to evaluate community pharmacy advanced practice experiences [J].
Cerulli, J ;
Malone, M .
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2003, 67 (02) :10P
[7]  
Ellingrod V.L., 2007, J PHARM PRACT, V20, P277, DOI DOI 10.1177/0897190007304820
[8]   Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects [J].
Evans, WE ;
McLeod, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :538-549
[9]   Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues [J].
Gage, Brian F. ;
Lesko, Lawrence J. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2008, 25 (01) :45-51
[10]   Education: Teaching pharmacogenornics to prepare future physicians and researchers for personalized medicine [J].
Gurwitz, D ;
Weizman, A ;
Rehavi, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (03) :122-125